Theoretical considerations suggest fat loss effects should continue as long as the compound is administered, since the mechanism (beta-3 adrenergic lipolysis, lipogenesis inhibition) does not involve receptor desensitization in the way that some hormonal pathways do
Tirzepatide Important Safety Information Regarding Compounded Tirzepatide Products Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy, similar to FDA-approved commercially available products
We wanted to look at this systematically in part to address the Catch-22 of third-party payers declining to cover these anti-obesity drugs because people quit them at a higher rate, when in truth some people stop the medications because coverage was terminated by the insurance company or the patient failed pre-authorization or they simply can't afford the out- of-pocket cost. Data is also important for clinicians and patients, he adds
Valencia, E., Marin, A., and Hardy, G
